We are live on ! Find out more
CCM

Concord Medical Services

13 hedge funds and large institutions have $18.6M invested in Concord Medical Services in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% less ownership

Funds ownership: 0.42%0.41% (-0.02%)

9% less capital invested

Capital invested by funds: $20.5M → $18.6M (-$1.87M)

24% less funds holding

Funds holding: 1713 (-4)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CCM Hedge Fund Activity: Q3 2017 in Review

13 of the 4,021 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q3 2017, worth a combined $18.6M — down 9.1% from $20.5M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CCM and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $10.9K. The largest seller was Letko, Brosseau & Associates, cutting an estimated $289K.

  • 13 institutional investors held Concord Medical Services (CCM) as of Q3 2017, down from 17 in Q2 2017.
  • Funds reported $18.6M of Concord Medical Services stock for Q3 2017, down 9.1% quarter-over-quarter.
  • 0 funds opened new Concord Medical Services positions in Q3 2017 and 3 closed out, a net change of -3 holders.
  • The largest Concord Medical Services buyer in Q3 2017 was UBS Group, an estimated $10.9K added.
  • The largest Concord Medical Services seller in Q3 2017 was Letko, Brosseau & Associates, an estimated $289K sold.

Based on aggregated 13F filings for Q3 2017.